Collectively, these findings suggested that GADD45A may positively modulate MGMT expression through the mutant TP53 pathway and thus regulate chemo-sensitivity in MGMT-proficient/TMZ-resistant GBM cells. The gene discussed is GADD45A; the disease is glioblastoma.